Policy Advocacy Toolkit for Medication-assisted Treatment (MAT) for Drug Dependence
|Iryna Reshevska, Karen Foreit, Kip Beardsley, and Lane Porter of HPI, TO1|
Full Document (pdf 1,929.7 kb)
The human, economic, and social costs of opioid dependence have increased exponentially with the advent of HIV and AIDS. In several regions of the world, most notably Eastern Europe and Eurasia, the unsterile sharing of needles, works, and drugs related to injecting drug use is the principal driver of HIV transmission and puts drug users, their partners, and sexual networks at risk. Medication-assisted treatment (MAT) programs are evidence-based drug treatment programs that result in drug users stopping drug use, changing risk behaviors, and reducing the risk of contracting or transmitting HIV. Most experts agree that the HIV epidemic in these countries cannot be contained without sustainable, widespread access to MAT and removal of barriers to MAT use.
The Toolkit's organizing principles were derived from the most up-to-date (as of mid-2010) international best practices for MAT, including guidance from the World Health Organization, the United Nations Office on Drugs and Crime, and the Joint United Nations Programme on HIV/AIDS (UNAIDS). The developers assembled an International Advisory Group and consulted extensively with group members throughout the process, as well as with various bureaus and field missions of the U.S. Agency for International Development (USAID), the Office of the Global AIDS Coordinator, and the Substance Abuse & Mental Health Services Administration (SAMHSA) of the U.S. Department of Health and Human Services (HHS). The European Harm Reduction Network identified national consultants to field test the instruments.
Click the group name to view all related publications.
|No. of Pages:||150|
|Country:||EUROPE and EURASIA, Europe and Eurasia Region|
|Keywords:||Policy Implementation, Care and Support, HIV/AIDS, Strategic Planning|